Surgalign Holdings, Inc. financial data

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
520 Lake Cook Road, Suite 315, Deerfield, IL
State of incorporation
DE
Fiscal year end
December 31
Former names
RTI Surgical Holdings, Inc. (to 7/15/2020), Bears Holding Sub, Inc. (to 2/7/2019)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 233 % -10.1%
Quick Ratio 70.1 % +29.6%
Debt-to-equity -2.65K % -948%
Return On Equity 1.76K %
Return On Assets -60.9 % -25.4%
Operating Margin -90.5 % +39.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.41M shares -95.8%
Common Stock, Shares, Outstanding 9.18M shares -95.4%
Entity Public Float 22.1M USD -87.3%
Common Stock, Value, Issued 8K USD -96%
Weighted Average Number of Shares Outstanding, Basic 8.07M shares +40.8%
Weighted Average Number of Shares Outstanding, Diluted 13.3M shares +125%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 78.1M USD -11%
Research and Development Expense 14.2M USD -8.19%
General and Administrative Expense 91.7M USD -11.5%
Operating Income (Loss) -70.7M USD +46.4%
Nonoperating Income (Expense) 19.1M USD -17.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -51.6M USD +52.5%
Income Tax Expense (Benefit) -1.07M USD -13.7%
Net Income (Loss) Attributable to Parent -50.5M USD +27.3%
Earnings Per Share, Basic -7.82 USD/shares +62%
Earnings Per Share, Diluted -8.36 USD/shares +59.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.4M USD -49.8%
Accounts Receivable, after Allowance for Credit Loss, Current 12.6M USD -38.5%
Inventory, Net 13.5M USD -41.1%
Assets, Current 53.4M USD -47.3%
Property, Plant and Equipment, Net 2.42M USD +169%
Operating Lease, Right-of-Use Asset 1.15M USD +30.2%
Other Assets, Noncurrent 5.71M USD -19.7%
Assets 67.7M USD -44.3%
Accounts Payable, Current 7.49M USD -38%
Employee-related Liabilities, Current 5.28M USD +19.9%
Accrued Liabilities, Current 12.1M USD -23.5%
Liabilities, Current 20M USD -29.5%
Operating Lease, Liability, Noncurrent 1.21M USD +36%
Other Liabilities, Noncurrent 7.91M USD +134%
Liabilities 76.6M USD -10.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.35M USD -73.6%
Retained Earnings (Accumulated Deficit) -620M USD -8.86%
Stockholders' Equity Attributable to Parent -18.9M USD -174%
Liabilities and Equity 67.7M USD -44.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.02M USD +52.9%
Net Cash Provided by (Used in) Financing Activities 13.6M USD -62.5%
Net Cash Provided by (Used in) Investing Activities 15.7M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 9.18M shares -95.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.14M USD
Deferred Tax Assets, Valuation Allowance 77.1M USD +18.6%
Operating Lease, Liability 1.5M USD +21.4%
Depreciation 2M USD -20%
Payments to Acquire Property, Plant, and Equipment 1.3M USD +2.86%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -49.1M USD +28.7%
Lessee, Operating Lease, Liability, to be Paid 2.56M USD +77.4%
Operating Lease, Liability, Current 290K USD -16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 452K USD +163%
Lessee, Operating Lease, Liability, to be Paid, Year One 462K USD +133%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.05M USD +419%
Lessee, Operating Lease, Liability, to be Paid, Year Three 397K USD +147%
Deferred Tax Assets, Operating Loss Carryforwards 36.4M USD +20.5%
Unrecognized Tax Benefits 2.08M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 393K USD +147%
Operating Lease, Payments 1.28M USD -4.25%
Depreciation, Depletion and Amortization 499K USD -11.2%
Deferred Tax Assets, Net of Valuation Allowance 1.49M USD +388%
Share-based Payment Arrangement, Expense 4.25M USD -24.9%
Interest Expense 1.01M USD +300%